Chroma Medicine
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
201 Brookline Ave Ste 1101, Boston, Mass...Phone Number
(781) 248-6114Website
www.chromamedicine.comRevenue
$16.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Chroma Medicine
Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, natures innate mechanism for gene regulation, to revolutionize treatment of disease.Explore more
Chroma Medicine Org Chart
TB
IP Vice President, Legal
CF
Vice President, Strategic Planning & Operatio...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chroma Medicine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Chroma Medicine launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Chroma Medicine
Click to see if Chroma Medicine had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Chroma Medicine has recently received funding, and reach out quickly before it becomes old news!
Chroma Medicine, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Chroma Medicine is spiking on competitors!
Funding: Get notified immidiatlly once Chroma Medicine has new funding data
Earning: See what the market has to say on Chroma Medicine recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Chroma Medicine as Masked Content
Find 2 more new buyers
Compare Similar Companies to Chroma Medicine
Compare insights from companies similar to Chroma Medicine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$8.2M
51-200
Private
-
1971
Company Profile Activity
Activity Insights
Chroma Medicine is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chroma Medicine is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chroma Medicine.
Chroma Medicine financials insights
Gather financial insights about Chroma Medicine, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$135M
Chroma Medicine Tech Stack
A closer look at the technologies used by Chroma Medicine
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Person-Based
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Left Company
Executive Move
Executive Moves, Left Company
Chroma Medicine News & Media
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
BOSTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Chroma Medicine and Nvelop Therapeutics unite to form nChroma Bio to redefine the future of in vivo targeted genetic medicine.Chroma Medicine Demonstrates Robust and Durable HBV Silencing with CRMA-1001 at 2024 International HBV Meeting
A single administration of CRMA-1001, a novel epigenetic editor, showed durable, dose-dependent reductions in viral antigens in an HBV AAV mouse model including > 99% reduction of HBsAg following a 0.5 mg/kg dose These results highlight the potential of Chroma's epigenetic editing...Chroma Medicine Presents Preclinical In Vivo Data Demonstrating Best-in-Class Potency and Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2024 ESC Congress
New NHP data indicate robust silencing at clinically relevant dose levels and highlight potential best-in-class potency achievable with Chroma's epigenetic editors Chroma's epigenetic editor achieved efficient and durable reductions in blood PCSK9 (84%) and LDL-cholesterol (68%) following...Chroma Medicine Appoints Renowned RNA Scientist Melissa Moore to Board of Directors
DR. MOORE BRINGS DEEP R&D EXPERIENCE TO THE COMPANY AS IT ADVANCES ITS VISION TO BRING NOVEL EPIGENETIC EDITING THERAPEUTICS TO PATIENTS BOSTON, July 18, 2024 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-course epigenetic editing...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Chroma Medicine
Sign Up For FreeTo access detailed company insights
Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, natures innate mechanism for gene regulation, to revolutionize treatment of disease.... Read More
